Literature DB >> 15139593

Nonvasculitic autoimmune inflammatory meningoencephalitis.

Keith A Josephs1, Frank A Rubino, Dennis W Dickson.   

Abstract

Caselli and colleagues described five cases with encephalopathy, progressive cognitive decline, ataxia, abnormal CSF studies and steroid responsiveness, and proposed the term non-vasculitic autoimmune inflammatory meningoencephalitis (NAIM). Many of these cases had brain biopsy showing mild leptomeningeal perivascular lymphocytic inflammation, however, none of the cases had a post-mortem. Nonvasculitic autoimmune mediated meningoencephalitis has been described in patients with Sjogren's syndrome, systemic lupus erythematosus and, more recently, with Hashimoto's disease. The present study is the first post-mortem report of a case with a clinical diagnosis of NAIM. Neuropathological examination revealed a panencephalitis with intact vessel walls. T and B immunostaining showed a mixture of T and B cells. The findings were not consistent with other reported findings in collagen vascular diseases including Sjogren's syndrome, CNS vasculitis or Hashimoto's encephalopathy. There was no evidence of neoplasia, bacteria, acid-fast bacilli, fungi or atypical infectious agents. This is the first post-mortem report of a case with a clinical diagnosis of NAIM and demonstrates a panencephalitis without evidence of a vasculitis. The pathology seems unique, however, Sjogren and Hashimoto's encephalopathy might be variants of NAIM.

Entities:  

Mesh:

Year:  2004        PMID: 15139593     DOI: 10.1111/j.1440-1789.2004.00542.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  10 in total

Review 1.  Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy).

Authors:  Gianluca Tamagno; Giovanni Federspil; Giovanni Murialdo
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Characterization of a severe parenchymal phenotype of experimental autoimmune encephalomyelitis in (C57BL6xB10.PL)F1 mice.

Authors:  Michael D Carrithers; Lisette M Carrithers; Jan Czyzyk; Octavian Henegariu
Journal:  J Neuroimmunol       Date:  2007-05-18       Impact factor: 3.478

Review 3.  Hashimoto's encephalopathy : epidemiology, pathogenesis and management.

Authors:  Ramon Mocellin; Mark Walterfang; Dennis Velakoulis
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 4.  Immunologically mediated dementias.

Authors:  Michael H Rosenbloom; Sallie Smith; Gulden Akdal; Michael D Geschwind
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

5.  Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case series.

Authors:  Farrah J Mateen; Keith A Josephs; Joseph E Parisi; Daniel A Drubach; Richard J Caselli; Kejal Kantarci; Clifford Jack; Bradley F Boeve
Journal:  Neurocase       Date:  2011-06-30       Impact factor: 0.881

6.  Successful response to intravenous immunoglobulin as rescue therapy in a patient with Hashimoto's encephalopathy.

Authors:  Rodrigo Cornejo; Pablo Venegas; Daniela Goñi; Alvaro Salas; Carlos Romero
Journal:  BMJ Case Rep       Date:  2010-12-29

7.  Steroid Responsive Encephalopathy Associated with Autoantibodies to Thyroperoxidase (STREAT), Presenting with Acute Stroke in a Young Female Patient.

Authors:  Eman Salah Heikal; Alshimaa Shaban Othman; Foad Abd-Allah
Journal:  J Vasc Interv Neurol       Date:  2017-12

Review 8.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

9.  Progressive cerebellar degeneration revealing Primary Sjögren Syndrome: a case report.

Authors:  Emna Farhat; Mourad Zouari; Ines Ben Abdelaziz; Cyrine Drissi; Rahma Beyrouti; Mohamed Ben Hammouda; Fayçal Hentati
Journal:  Cerebellum Ataxias       Date:  2016-10-19

10.  Hashimoto's encephalopathy - presenting with epilepsia partialis continua and a frontal lobe lesion.

Authors:  Lokesh A Rukmangadachar; Sudeepta Dandapat; Esther N Bit-Ivan; Yen-Yi Peng
Journal:  Clin Case Rep       Date:  2017-12-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.